Vantis Vascular - About the company
Vantis Vascular is a series C company based in San Jose (United States), founded in 2022. It operates as a Provider of a medical device for vascular interventions. Vantis Vascular has raised $30M in funding. The company has 119 active competitors, including 45 funded and 28 that have exited. Its top competitors include companies like TISSIUM, Vivasure Medical and Laminate Medical.
Company Details
Provider of a medical device for vascular interventions. It focuses on developing performance driven technology for vascular interventions. It allows the inner microcatheter and outer delivery catheter to one unit when locked, providing pushability to traverse through the most calcific and tortuous anatomies.
- Website
- vantisvascular.com
- Email ID
- *****@vantisvascular.com
Key Metrics
Founded Year
2022
Location
San Jose, United States
Stage
Series C
Total Funding
$30M in 5 rounds
Latest Funding Round
Investors
Ranked
30th among 119 active competitors
Employee Count
19 as on Jul 31, 2026
Sign up to download Vantis Vascular's company profile
Vantis Vascular's funding and investors
Vantis Vascular has raised a total funding of $30M over 5 rounds. Its first funding round was on May 21, 2024. Vantis Vascular has 1 institutional investor.
Here is the list of recent funding rounds of Vantis Vascular:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 10, 2026 | 8729175 | Series C | 1258402 | 9744089 | 7312183 | 7476604 |
Jan 30, 2025 | 7951920 | Grant (prize money) | 6164090 | 7533003 | 9815412 | |
Jan 17, 2025 | 5079073 | Grant (prize money) | 1162107 | 7974132 | 1417119 |
Access funding benchmarks and valuations. Sign up today!View details of Vantis Vascular's funding rounds and investors
Vantis Vascular's founders and board of directors
Founder? Claim ProfileVantis Vascular's employee count trend
Vantis Vascular has 19 employees as of Jul 26. Here is Vantis Vascular's employee count trend over the years:
Uncover Vantis Vascular's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Vantis Vascular's Competitors and alternates
Top competitors of Vantis Vascular include TISSIUM, Vivasure Medical and Laminate Medical. Here is the list of Top 10 competitors of Vantis Vascular, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of vascular sealant for open vascular surgery | $190M | 66/100 | ||
2nd |  Vivasure Medical 2009, Galway (Ireland), Acquired | Developer of polymer implants and delivery systems | $92.1M | 61/100 | |
3rd | Laminate Medical 2012, Rehovot (Israel), Series C | Device to prevent AV Fistula failure by promoting their maturation and patency | $20M | 52/100 | |
4th | EKOS Corporation 1995, Bothell (United States), Acquired | Developer of a device for thrombolysis to treat pulmonary embolism | $58.8M | 52/100 | |
5th | ivWatch 2010, Williamsburg (United States), Series E | Detecting Intravenous infiltration | $90.1M | 50/100 | |
6th | AccessClosure 2002, Mountain View (United States), Acquired | Vascular closure device | $18.7M | 50/100 | |
7th | Access Vascular 2015, Bedford (United States), Series C | Developer of hydrogel-based devices to improve venous access | $54.3M | 50/100 | |
8th | Semprus BioSciences 2006, Cambridge (United States), Acquired | Provider of bio-functional medical surfaces to interface between the body and implantable devices | $26M | 50/100 | |
9th | Cardival Medical 2002, Santa Clara (United States), Acquired | Developer of a device for vascular access management | $169M | 49/100 | |
10th | Vascular access device for hemodialysis | $14.4M | - | 48/100 | |
30th |  Vantis Vascular 2022, San Jose (United States), Series C | Provider of a medical device for vascular interventions | $30M | 48/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Vantis Vascular's competitors? Click here to see the top ones
Vantis Vascular's Investments and acquisitions
Vantis Vascular has made no investments or acquisitions yet.
Reports related to Vantis Vascular
Here is the latest report on Vantis Vascular's sector:
News related to Vantis Vascular
Media has covered Vantis Vascular for 1 event in last 1 year.
•
Vantis Vascular Files Notice for Exempt Offering to Raise $21.5 Million in New Fundingintelligence360•Aug 10, 2026•Vantis Vascular
•
Vantis Vascular Announces Superior Clinical Performance Of The Crossfast Advanced Delivery System In First Commercial CasesPR Newswire•Jan 23, 2025•Vantis Vascular
•
Vantis Vascular Closes $10m In Series B-1 Preferred FinancingPR Newswire•Dec 12, 2024•Vantis Vascular
•
Vantis Vascular has filed a notice of an exempt offering of securities to raise $22,199,202.00 in New Equity Investment.intelligence360•Oct 28, 2024•Vantis Vascular
•
Vantis Vascular Receives Fda Clearance For Its Crossfast™ Guide Extension SystemPR Newswire•Oct 25, 2024•Vantis Vascular
•
Vantis Vascular Secures $5 Million in Safe Financing to Drive Innovation in Vascular InterventionsPR Newswire•May 21, 2024•Vantis Vascular
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Vantis Vascular
Explore our recently published companies
- MIRSTAR - Unfunded company
- Veadicastro - Dehradun based, 2025 founded, Unfunded company
- Jodi Grasso - Unfunded company
- Nautilus Labs - United States based, 2024 founded, Unfunded company
- Elite Strategic - Milan based, Unfunded company
- Sigma of Senses - San Francisco based, Unfunded company
